We asked 40 pharma leaders, 2012 has been touted as a crucial year of the so-called patent cliff. Do you think the impact of patent expiries has been better or worse than expected?
Obama Win: Full Speed Ahead on US Healthcare Reform With the Presidential election decided, it's time for pharma to get down to business on the implementation of ObamaCare. Here are some of the key actions to anticipate between now and January 1, 2013... Read more
EC Approves Europe's First Gene Therapy The European Commission (EC) has issued final approval for Europe's first gene therapy — a treatment for a rare genetic disorder that currently has no other treatment options... Read more
Sciformix's Integrated Drug Safety solution seamlessly interweaves and synchronizes services across all phases of the product lifecycle. Our unitary approach to risk management provides your organization with updated safety profiles of your developmental and licensed products to assist in addressing emerging safety issues and regulatory requests in a comprehensive and timely manner. Read more
